Reduced-Antigen, Combined Diphtheria-Tetanus-Acellular Pertussis Vaccine, Adsorbed (Boostrix® US Formulation) Use as a Single-Dose Booster Immunization in …

JE Frampton, SJ Keam - Pediatric Drugs, 2006 - Springer
Abstract▲ Boostrix® US formulation (hereafter referred to as Tdap) is a formulation of
reduced-antigen, combined diphtheria-tetanus-acellular pertussis vaccine, adsorbed onto …

Reduced-antigen, combined diphtheria-tetanus-acellular pertussis vaccine, adsorbed (Boostrix) US formulation): use as a single-dose booster immunization in …

JE Frampton, SJ Keam - Paediatric drugs, 2006 - pubmed.ncbi.nlm.nih.gov
black triangle Boostrix US formulation (hereafter referred to as Tdap) is a formulation of
reduced-antigen, combined diphtheria-tetanus-acellular pertussis vaccine, adsorbed onto …

Reduced-antigen, combined diphtheria-tetanus-acellular pertussis vaccine, adsorbed (Boostrix) US formulation): use as a single-dose booster immunization in …

JE Frampton, SJ Keam - Paediatric Drugs, 2006 - europepmc.org
black triangle Boostrix US formulation (hereafter referred to as Tdap) is a formulation of
reduced-antigen, combined diphtheria-tetanus-acellular pertussis vaccine, adsorbed onto …

Reduced-antigen, combined diphtheria-tetanus-acellular pertussis vaccine, adsorbed (Boostrix [R] US formulation): use as a single-dose booster immunization in …

JE Frampton, SJ Keam - Pediatric Drugs, 2006 - go.gale.com
Boostrix [R] US formulation (hereafter referred to as Tdap) is a formulation of reduced-
antigen, combined diphtheria-tetanus-acellular pertussis vaccine, adsorbed onto aluminium …